Position in TMO
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$1,441,410
-$269,605 QoQ
Shares Held
2,875
-17.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,294
of 2,602 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cooper Financial Group holds $2,839,590 across 4 Diagnostics & Research names. TMO ranks #1 (50.8% of the industry book) .
All Filings in TMO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,441,410 | 2,875 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $1,711,015 | 3,481 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,437,615 | 2,481 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,209,639 | 2,494 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $959,318 | 2,366 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,198,220 | 2,408 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,034,217 | 1,988 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,221,675 | 1,975 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $434,105 | 785 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $282,468 | 486 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $248,940 | 469 | Shares | Sole | 2024-01-16 | |
| No filing history on record for this holder in this stock. | ||||||